The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations.
about
The respiratory syncytial virus polymerase has multiple RNA synthesis activities at the promoterSynthesis of human parainfluenza virus 2 nucleocapsid protein in yeast as nucleocapsid-like particles and investigation of its antigenic structure.Common position of indels that cause deviations from canonical genome organization in different measles virus strains.Complete genome sequence and pathogenicity of two swine parainfluenzavirus 3 isolates from pigs in the United States.Wheat germ cell-free system-based production of hemagglutinin-neuraminidase glycoprotein of human parainfluenza virus type 3 for generation and characterization of monoclonal antibodyHuman parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys.Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates.Progress in the development of human parainfluenza virus vaccinesInterplay between innate immunity and negative-strand RNA viruses: towards a rational modelThe two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatednessIdentification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primatesGene-specific contributions to mumps virus neurovirulence and neuroattenuation.Competition between the Sendai virus N mRNA start site and the genome 3'-end promoter for viral RNA polymeraseRecombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates.VIGOR extended to annotate genomes for additional 12 different viruses.New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium.The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.The complete sequence of a human parainfluenzavirus 4 genome.First complete genome sequence of parainfluenza virus 5 isolated from lesser panda.Vero/BC-F: an efficient packaging cell line stably expressing F protein to generate single round-infectious human parainfluenza virus type 2 vector.Genome Sequences of Three Novel Isolates of Human Parainfluenza Virus 2 Associated with Acute Respiratory Infection.The Ebola virus genomic replication promoter is bipartite and follows the rule of six.Genetic analysis of human parainfluenza viruses circulating in Korea, 2006.
P2860
Q28484478-B8E66B76-34AC-4E98-A223-5150AE553B96Q30383975-C4C4FB59-8DBC-4706-A8FB-57F05FD1B3BAQ30489638-11FEA656-6CFE-4F59-BBEE-26326EE41BECQ33558465-37186065-4DD5-4286-A4FD-AF9109746ACCQ33633800-91F27F7A-8512-4F6C-AB2E-8C5F4EBC795FQ33653692-2BF26F26-0091-4DCF-9AFA-E758B5A0B9A7Q33748766-1B4DABEA-F477-40C3-9534-99DE79C06FC8Q34101229-1F996824-FD2A-44C5-80DA-DC07CC99A392Q34209872-9C4446C2-4A0A-4713-9346-92BBA1AFFDB7Q34212787-7D9642A1-76C2-4CEE-8A45-1FFC1F410A26Q34439107-82D44797-C7D2-4E98-98A6-1192015B93D7Q35076577-49E1A283-D404-492B-A9D4-E5658AA3B355Q35077685-12DF5F56-899E-4C5F-95CF-C9E3AC37432FQ35802939-9F66E84D-B31E-4733-B57E-9FE923B8166DQ36088161-CAE65629-D46F-4E3D-94F6-AE5074FD8276Q36088457-6A3C98AB-0AF5-431F-80B2-28616179CB83Q36237057-769E69A7-B470-4009-A9F6-D350EE38598CQ36312804-72718564-5162-461B-A6B7-9059C236E132Q37157191-1ED67056-B5A5-4193-89D2-C34D3594F041Q38613005-38FBF34D-2F6F-455A-834A-2D48DBFC069CQ38718689-CBD54E49-1A1A-4941-9285-B182DD945ACEQ38983275-F1A9A511-058F-459F-96C8-81B91FE77A9FQ40079003-99514C47-8775-4706-93D9-3CB4076005B3Q40502565-EA706151-9684-4311-8093-F8FDDBA9F992Q42231243-8EF75BCF-C4DE-4359-B181-5F4EF6315C07
P2860
The genome length of human parainfluenza virus type 2 follows the rule of six, and recombinant viruses recovered from non-polyhexameric-length antigenomic cDNAs contain a biased distribution of correcting mutations.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The genome length of human par ...... ution of correcting mutations.
@ast
The genome length of human par ...... ution of correcting mutations.
@en
The genome length of human par ...... ution of correcting mutations.
@nl
type
label
The genome length of human par ...... ution of correcting mutations.
@ast
The genome length of human par ...... ution of correcting mutations.
@en
The genome length of human par ...... ution of correcting mutations.
@nl
prefLabel
The genome length of human par ...... ution of correcting mutations.
@ast
The genome length of human par ...... ution of correcting mutations.
@en
The genome length of human par ...... ution of correcting mutations.
@nl
P2093
P2860
P1433
P1476
The genome length of human par ...... ution of correcting mutations.
@en
P2093
Brian R Murphy
Jeffrey M Riggs
Leatrice Vogel
Mario H Skiadopoulos
Peter L Collins
Sonja R Surman
P2860
P304
P356
10.1128/JVI.77.1.270-279.2003
P407
P577
2003-01-01T00:00:00Z